Acute lymphocytic or lymphoblastic leukemia is sometimes called ALL. It starts in the bone marrow where blood cells are made. It is more common in children than in adults. Get an overview of acute lymphocytic leukemia and the latest key statistics in the US. Learn about the risk factors for acute lymphocytic leukemia and if there are things you might be able to do to help lower your risk.
Questions to Ask about Your Treatment. Weston, Lhmphoblastic. Read more. These are all tests that are performed on a sample obtained from the bone marrow. For example, in Philadelphia chromosome —positive ALL, part of one chromosome Acute lymphoblastic leukemia adults places with part of another chromosome. National Cancer Institute. Adult ALL is frequently associated with abnormal chromosomes of the leukemia cells. Immunotherapy Patients may want to think about taking part in a clinical trial. Search Sex hummers. Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the laboratory, from a single type of immune system cell.
Hilton head horseback riding. Stages of Adult Acute Lymphoblastic Leukemia
Cancer Training at NCI. The cancer drug, vincristinehas been the main chemotherapy used for ALL Acute lymphoblastic leukemia adults adults. Treatment ALL is classified as: Untreated. Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack Telegraph jeffrey greene sexual harassment cancer cells without harming normal cells. Identifying your triggers can take some time and self-reflection. The date on each summary "Updated" is the date of the most recent change. Cancer A-Z. Enlarge Philadelphia chromosome. Grants Management Contacts. From tothe five-year survival rate for all ages was under 40 percent. Building a Diverse Workforce. Side effects from cancer treatment that begin after treatment and continue for months or years are called late leeukemia. This type of cancer usually gets worse quickly if it is not treated. Standard treatment of adult ALL during the post-remission phase includes the following:.
This article is a more specific discussion of ALL.
- Acute lymphocytic leukemia ALL is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.
- Acute lymphocytic leukemia ALL is a form of cancer.
- Adult acute lymphoblastic leukemia ALL; also called acute lymphocytic leukemia is a cancer of the blood and bone marrow.
This article is a more specific discussion of ALL. Please be sure to read Leukemia: The Basics first, so you have a basic understanding of leukemia. ALL is a blood cancer that affects the white blood cells. Lymphocytes are further broken down into B and T cell lymphocytes. ALL is a spectrum of disease comprised of several different subtypes, named for the cell type that is affected B or T and how abnormal the cell appears under a microscope. A person with ALL develops abnormal numbers of white blood cells rather quickly, usually over weeks, giving the disease the name "acute".
The white blood cell WBC count may be higher or lower than normal, but the WBCs that are being produced are immature and do not function well. Because WBCs are an important part of fighting infections, patients often have multiple infections that don't respond to treatment before they are diagnosed. Some people will have low red blood cell or platelet counts because the overpopulation of WBCs crowds out these cells.
In most cases, the cause of ALL is unknown. There are some factors that are known to increase a person's risk of developing ALL, including previous treatment with chemotherapy or radiation therapy, exposure to large amounts of radiation such as an atomic bomb , or the presence of a genetic disorder including Down syndrome, Klinefelter's syndrome, neurofibromatosis, and Fanconi anemia. ALL accounts for 0. ALL can occur at any age, but is most common in children, ages 2 to 4, and adults over age This article will address ALL in adults.
It impacts women and men equally and has a slightly higher incidence in Hispanics. There are no standard screening tests used for ALL. Be sure to tell your health care providers of any history of being exposed to radiation as in an atomic bomb detonation or nuclear accident , or if you have a genetic syndrome be sure to discuss your potential increased risk for developing ALL. In ALL, white blood cells do not fully mature and therefore cannot function properly.
These immature cells, called "blasts", also suppress normal blood cells from forming, further compounding the problem. Symptoms can include weight loss, fever, infection, easy bleeding or bruising, shortness of breath, or weakness. These symptoms can also be signs of common illnesses, like a cold or flu, and it is not uncommon for a person to be seen several times by a healthcare provider before receiving a diagnosis of ALL.
Most infections are just infections and not leukemia, so treating a suspected infection is appropriate and this short delay in diagnosis is not likely to affect the course of the disease.
What is important is that a person returns to their healthcare provider for further investigation if the symptoms they have do not respond to the prescribed treatment often antibiotics. When blood counts are checked, abnormal counts of blasts are seen on the results.
Once this occurs, further testing is required to clarify a diagnosis of leukemia and determine the type of ALL. On a blood smear, blast cells are usually seen.
A bone marrow biopsy confirms the diagnosis and allows the laboratory to determine the sub type. A lumbar puncture spinal tap is also done to evaluate if there are blast cells in the spinal fluid.
You may also have tests to determine if there are chromosomal abnormalities karyotyping or cytogenetic analysis. Other laboratory tests that may be preformed include a FISH fluorescence in situ hybridization test and a PCR polymerase chain reaction.
Your cells will also be examined through a process called immunophenotyping which helps to determine what subtype of ALL you have.
These classifications are made based on the chromosomal and genetic abnormalities present in the cells. They also guide the treatment of the disease. You may hear your care team identify the leukemia by the chromosomal or genetic abnormalities, which are described below.
The "t" stands for translocation and the p, q and v have to do with the location of the abnormality on the chromosome.
Chemotherapy for ALL is one of the most complex treatment plans used in any type of cancer. It is broken down into three phases, induction phase, consolidation or intensification phase and maintenance phase.
Surgery is not used because ALL is a disease of the blood, which circulates throughout the whole body. This means an effective treatment must address disease throughout the body. The selection of a chemotherapy regimen is dependent on age, as well as the sub-type of ALL. These medications are called tyrosine kinases inhibitors TKIs. This regimen is called hyper-CVAD. Other chemotherapeutic medications may be used based on the subtype of ALL.
Many patients will be treated as part of a clinical trial to allow researchers to better identify the best regimens. Consolidation therapy uses some similar medications, but is more variable in its schedule, depending upon the particular subtype of ALL.
Consolidation is given over a period of 4 to 8 months. If a patient was a candidate for stem cell transplant, then the transplant would likely be done in lieu of consolidation and maintenance therapy.
Studies found no benefit to increasing this time, but did find outcomes to be worse if the maintenance period was shorter. Maintenance therapy is not given for Burkitt's lymphoma leukemia, as this subtype has a high cure rate with induction and consolidation therapy alone. A new type of immunotherapy, called adoptive cell transfer ACT was approved.
Because of potential risk to fertility associated with chemotherapy medications used to treat ALL, discuss fertility preservation options with your healthcare provider before starting treatment. This involves giving chemotherapy directly into the spinal canal.
This catheter allows for multiple, repeat intrathecal infusions without needing multiple lumbar punctures. The number of intrathecal infusions given is dependent on the subtype of ALL and the risk of CNS disease associated with that subtype. It is most often used early in therapy for patients with high-risk subtypes of ALL in first remission. Clinical trials are evaluating the optimal time for transplant first or second remission, before maintenance therapy, etc.
People with leukemia are at risk of infection due to few and poorly functioning white blood cells and bleeding due to low platelet counts even before any therapy is started. Because these abnormalities are a result of the leukemia, it is necessary to treat the leukemia in order to correct the abnormal blood counts. Leukemia treatment causes the blood cell counts and function to temporarily get worse.
During this time, patients will receive blood and platelet transfusions, antibiotics and take precautions to prevent infection and bleeding. Hand washing is the single best way to prevent infection and should be performed frequently by patients, visitors, caregivers and healthcare personnel.
Even the best hand washers get infections, so we implement a few other restrictions to help in the cause. People with leukemia may have restrictions on consuming some types of fresh fruit and vegetables or receiving fresh flowers or plants while in the hospital. See the gift guide for ideas on what to send a patient with these restrictions You may think this sounds odd, but these items can harbor bacteria and may put the patient at higher risk of infection. We ask people who are sick or who have sick family members at home not visit the patient in person and if they absolutely must, they need to wear a mask and wash their hands well.
In most cases, some type of infection or fever is inevitable. When this happens, the patient will typically have several tests done to look for a source of the infection, which can include blood, urine and stool cultures, and a chest x-ray. Antibiotics may be started, or adjusted if they are already being given.
Many times the source of the infection is never identified and general antibiotics that treat a variety of things will be used. The patient will receive these antibiotics until their white blood count reaches a level that will allow them to fight the infection on their own. Over the course of their treatment, patients will require either blood for low hemoglobin levels or platelet for low platelet counts transfusions.
This can be as small as gums bleeding when brushing the teeth or a nosebleed, to dangerous bleeding, such as a stroke. Patients should use caution to avoid bumping themselves with normal activities; they should not shave with a razor electric razor is okay, with caution and should avoid any activities that increase the risk of bleeding or bruising. Patients should always inform their healthcare team if they have symptoms of anemia or thrombocytopenia. A diagnosis of leukemia is very scary, but understanding what is happening and what to expect can help alleviate some anxiety.
Learning about the treatments, potential side effects and how the healthcare team will manage them can help patients and their caregivers, friends and family.
There are clinical research trials for most types of cancer, and every stage of the disease. Clinical trials are designed to determine the value of specific treatments.
Trials are often designed to treat a certain stage of cancer, either as the first form of treatment offered, or as an option for treatment after other treatments have failed to work. They can be used to evaluate medications or treatments to prevent cancer, detect it earlier, or help manage side effects. Clinical trials are extremely important in furthering our knowledge of disease.
It is through clinical trials that we know what we do today, and many exciting new therapies are currently being tested. Talk to your provider about participating in clinical trials in your area. Once you have been treated for ALL, you will need to be closely followed by your oncology team. At first, you will have follow-up visits fairly often.
For the first year you will have a physical exam, and CBC lab draw with differential monthly. Re-examinations of bone marrow aspirate, cerebrospinal fluid CSF , and echocardiogram may be ordered based on your disease process, genetics, and treatment.
This will be determined by your health care team. In the second year, you will have a physical exam and CBC with differential every 3 months. Depending upon your age at time of diagnosis you may also have regular testicular exams.
Fear of recurrence, relationship challenges, financial impact of cancer treatment, employment issues, and coping strategies are common emotional and practical issues experienced by ALL survivors. Your healthcare team can identify resources for support and management of these practical and emotional challenges faced during and after cancer.
Cancer survivorship is a relatively new focus of oncology care. With some 15 million cancer survivors in the US alone, there is a need to help patients transition from active treatment to survivorship. What happens next, how do you get back to normal, what should you know and do to live healthy going forward?
A survivorship care plan can be a first step in educating yourself about navigating life after cancer and helping you communicate knowledgeably with your healthcare providers. Beldjord, K. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.
Questions to Ask about Your Diagnosis. Each part of its name tells you something about the cancer itself:. A clinical trial of new anticancer drugs. Available for Android and iOS devices. For some patients, taking part in a clinical trial may be the best treatment choice. ALL is the most common childhood cancer , but it has high cure rates in children. Treatment of relapsed or refractory acute lymphoblastic leukemia in adults.
Acute lymphoblastic leukemia adults. Stages of Adult Acute Lymphoblastic Leukemia
Acute Lymphocytic Leukemia (ALL) in Adults
Back to Health A to Z. Acute lymphoblastic leukaemia is a type of cancer that affects white blood cells. It progresses quickly and aggressively and requires immediate treatment. Both adults and children can be affected.
Acute lymphoblastic leukaemia is rare, with around people diagnosed with the condition each year in the UK. Most cases of acute lymphoblastic leukaemia develop in children, teenagers and young adults. Although it is rare, acute lymphoblastic leukaemia is the most common type of leukaemia that affects children.
It affects slightly more boys than girls. All the blood cells in the body are produced by bone marrow, which is a spongy material found inside bones. Bone marrow produces stem cells, which have the ability to develop into three important types of blood cells:. Bone marrow does not usually release stem cells into the blood until they have become fully developed blood cells.
But in acute lymphoblastic leukaemia, large numbers of white blood cells are released before they are ready. As the number of blast cells increases, the number of red blood cells and platelet cells decreases. This causes the symptoms of anaemia , such as tiredness, breathlessness and an increased risk of excessive bleeding.
Also, blast cells are less effective than mature white blood cells at fighting bacteria and viruses, making you more vulnerable to infection. In some cases, the affected cells can spread from your bloodstream into your central nervous system. This can cause neurological symptoms related to the brain and nervous system , including:. If you or your child has some or all the symptoms listed on this page, it's still highly unlikely that acute leukaemia is the cause.
However, see a GP as soon as possible because any condition that causes these symptoms needs prompt investigation and treatment. Find out more about diagnosing acute lymphoblastic leukaemia. A genetic change mutation in the stem cells causes immature white blood cells to be released into the bloodstream.
Extensive research has been done to determine whether the following environmental factors could be a trigger for leukaemia:. There's currently no firm evidence to suggest that any of these environmental factors increases the risk of developing leukaemia. Cancer Research UK has more information about acute lymphoblastic leukaemia risks and causes. As acute lymphoblastic leukaemia is an aggressive condition that develops quickly, treatment usually begins a few days after diagnosis.
Chemotherapy is the main treatment for acute lymphoblastic leukaemia. Sometimes a stem cell transplant may also be needed to achieve a cure. Find out more about treating acute lymphoblastic leukaemia. If a cure for acute lymphoblastic leukaemia is not possible, there's a risk that the lack of healthy blood cells can make the person:.
These two complications, and others, are discussed further in complications of acute lymphoblastic leukaemia. One of the biggest factors that affects the outlook for people with acute lymphoblastic leukaemia is age. The younger a person is when they are diagnosed and treatment begins, the better the outlook. If you or a family member has been diagnosed with acute lymphoblastic leukaemia, Leukaemia Care provides further information, advice and support.
The charity Cancer UK also has more information about acute lymphoblastic leukaemia. Page last reviewed: 30 September Next review due: 30 September What happens in acute lymphoblastic leukaemia All the blood cells in the body are produced by bone marrow, which is a spongy material found inside bones. Bone marrow produces stem cells, which have the ability to develop into three important types of blood cells: red blood cells — which carry oxygen around the body white blood cells — which help fight infection platelets — which help stop bleeding Bone marrow does not usually release stem cells into the blood until they have become fully developed blood cells.
Most of the symptoms are caused by a lack of healthy blood cells. Treating acute lymphoblastic leukaemia As acute lymphoblastic leukaemia is an aggressive condition that develops quickly, treatment usually begins a few days after diagnosis. Complications of acute lymphoblastic leukaemia If a cure for acute lymphoblastic leukaemia is not possible, there's a risk that the lack of healthy blood cells can make the person: extremely vulnerable to life-threatening infections because they do not have enough healthy white blood cells to fight infections prone to uncontrolled and serious bleeding because there are not enough platelets in their blood These two complications, and others, are discussed further in complications of acute lymphoblastic leukaemia.
Outlook One of the biggest factors that affects the outlook for people with acute lymphoblastic leukaemia is age. From the available data in England it is estimated that: in those aged 14 or younger, more than 9 in 10 will survive leukaemia for 5 years or longer after diagnosis in those aged 15 to 24, almost 7 in 10 will survive leukaemia for 5 years or longer after diagnosis in those aged 25 to 64, almost 4 in 10 will survive leukaemia for 5 years or longer after diagnosis in those aged 65 or older, almost 15 in will survive leukaemia for 5 years or longer after diagnosis Help and support Find more information about cancer.
Call Leukaemia Care's free helpline on or email: support leukaemiacare.